chr12-32582302-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001370298.3(FGD4):​c.846C>T​(p.Asp282Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.403 in 1,613,920 control chromosomes in the GnomAD database, including 135,666 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 18375 hom., cov: 33)
Exomes 𝑓: 0.40 ( 117291 hom. )

Consequence

FGD4
NM_001370298.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.847
Variant links:
Genes affected
FGD4 (HGNC:19125): (FYVE, RhoGEF and PH domain containing 4) This gene encodes a protein that is involved in the regulation of the actin cytoskeleton and cell shape. This protein contains an actin filament-binding domain, which together with its Dbl homology domain and one of its pleckstrin homology domains, can form microspikes. This protein can activate MAPK8 independently of the actin filament-binding domain, and it is also involved in the activation of CDC42 via the exchange of bound GDP for free GTP. The activation of CDC42 also enables this protein to play a role in mediating the cellular invasion of Cryptosporidium parvum, an intracellular parasite that infects the gastrointestinal tract. Mutations in this gene can cause Charcot-Marie-Tooth disease type 4H (CMT4H), a disorder of the peripheral nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 12-32582302-C-T is Benign according to our data. Variant chr12-32582302-C-T is described in ClinVar as [Benign]. Clinvar id is 308287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-32582302-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.847 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.675 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGD4NM_001370298.3 linkc.846C>T p.Asp282Asp synonymous_variant Exon 4 of 17 ENST00000534526.7 NP_001357227.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGD4ENST00000534526.7 linkc.846C>T p.Asp282Asp synonymous_variant Exon 4 of 17 5 NM_001370298.3 ENSP00000449273.1 F8VWL3

Frequencies

GnomAD3 genomes
AF:
0.472
AC:
71661
AN:
151970
Hom.:
18352
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.682
Gnomad AMI
AF:
0.516
Gnomad AMR
AF:
0.510
Gnomad ASJ
AF:
0.423
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.402
Gnomad FIN
AF:
0.328
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.469
GnomAD3 exomes
AF:
0.411
AC:
103295
AN:
251402
Hom.:
22590
AF XY:
0.406
AC XY:
55148
AN XY:
135876
show subpopulations
Gnomad AFR exome
AF:
0.686
Gnomad AMR exome
AF:
0.509
Gnomad ASJ exome
AF:
0.436
Gnomad EAS exome
AF:
0.226
Gnomad SAS exome
AF:
0.420
Gnomad FIN exome
AF:
0.329
Gnomad NFE exome
AF:
0.382
Gnomad OTH exome
AF:
0.426
GnomAD4 exome
AF:
0.395
AC:
577859
AN:
1461832
Hom.:
117291
Cov.:
62
AF XY:
0.396
AC XY:
287725
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.695
Gnomad4 AMR exome
AF:
0.509
Gnomad4 ASJ exome
AF:
0.432
Gnomad4 EAS exome
AF:
0.212
Gnomad4 SAS exome
AF:
0.419
Gnomad4 FIN exome
AF:
0.332
Gnomad4 NFE exome
AF:
0.387
Gnomad4 OTH exome
AF:
0.411
GnomAD4 genome
AF:
0.472
AC:
71745
AN:
152088
Hom.:
18375
Cov.:
33
AF XY:
0.469
AC XY:
34831
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.682
Gnomad4 AMR
AF:
0.510
Gnomad4 ASJ
AF:
0.423
Gnomad4 EAS
AF:
0.222
Gnomad4 SAS
AF:
0.402
Gnomad4 FIN
AF:
0.328
Gnomad4 NFE
AF:
0.383
Gnomad4 OTH
AF:
0.467
Alfa
AF:
0.393
Hom.:
20180
Bravo
AF:
0.499
EpiCase
AF:
0.400
EpiControl
AF:
0.403

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 4H Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jul 12, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.20
DANN
Benign
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs904582; hg19: chr12-32735236; COSMIC: COSV56781591; COSMIC: COSV56781591; API